Literature DB >> 29873358

An estrogen receptor targeted ruthenium complex as a two-photon photodynamic therapy agent for breast cancer cells.

Xueze Zhao1, Mingle Li, Wen Sun, Jiangli Fan, Jianjun Du, Xiaojun Peng.   

Abstract

In this study, we reported a tamoxifen modified Ru(ii) polypyridyl complex (Ru-tmxf) as an estrogen receptor (ER) targeted photosensitizer. Ru-tmxf displays enhanced cellular uptake and PDT efficiency toward breast cancer cells with high ER expression due to the specific targeting of tamoxifen to ER and finally localizes in lysosomes. Moreover, Ru-tmxf can be activated by two-photon excitation, generating 1O2 to damage lysosomes and result in cell death.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29873358     DOI: 10.1039/c8cc03786h

Source DB:  PubMed          Journal:  Chem Commun (Camb)        ISSN: 1359-7345            Impact factor:   6.222


  5 in total

Review 1.  Photodynamic therapy in breast cancer treatment.

Authors:  Joanna Gustalik; David Aebisher; Dorota Bartusik-Aebisher
Journal:  J Appl Biomed       Date:  2022-10-04       Impact factor: 0.500

Review 2.  Emerging Molecular Receptors for the Specific-Target Delivery of Ruthenium and Gold Complexes into Cancer Cells.

Authors:  João Franco Machado; João D G Correia; Tânia S Morais
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

3.  A light-induced nitric oxide controllable release nano-platform based on diketopyrrolopyrrole derivatives for pH-responsive photodynamic/photothermal synergistic cancer therapy.

Authors:  Ya Wang; Xiaoyu Huang; Yunyun Tang; Jianhua Zou; Peng Wang; Yewei Zhang; Weili Si; Wei Huang; Xiaochen Dong
Journal:  Chem Sci       Date:  2018-08-29       Impact factor: 9.825

Review 4.  Applications of Ruthenium Complex in Tumor Diagnosis and Therapy.

Authors:  Ke Lin; Zi-Zhuo Zhao; Hua-Ben Bo; Xiao-Juan Hao; Jin-Quan Wang
Journal:  Front Pharmacol       Date:  2018-11-19       Impact factor: 5.810

Review 5.  Rationally Designed Ruthenium Complexes for Breast Cancer Therapy.

Authors:  Golara Golbaghi; Annie Castonguay
Journal:  Molecules       Date:  2020-01-09       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.